Skip to main content
Clinical Trials/CTRI/2018/11/016345
CTRI/2018/11/016345
Active, Not Recruiting
Phase 3

A prospective study to evaluate the feasibility of hippocampal sparing intensity modulated radiotherapy in preserving neurocognitive functions in adult patients with pituitary adenoma.

Tata Memorial Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: G938- Other specified disorders of brainHealth Condition 2: null- Patients above 18 years of age diagnosed with pituitary adenomas.
Sponsor
Tata Memorial Hospital
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients must provide study\-specific informed consent prior to study enrolment
  • 2\.Indication for adjuvant /radical radiotherapy
  • 3\.Patients who are treated in TMH Mumbai / ACTREC Navi Mumbai
  • 4\.Age \> 18years
  • 5\.Patients consenting for the study
  • 6\.Karnofsky Performance Score of \> 70

Exclusion Criteria

  • 1\. Prior history of irradiation to head \& neck region
  • 2\. Contraindication to MR imaging such as implanted metal devices, severe claustrophobia etc
  • 3\. Acute medical illness requiring intensive medical care.
  • 4\. Any evidence of chronic / severe or uncontrolled medical illnesses
  • 5\. Patients with known major psychiatric illness, on antipsychotic medications and/or on electroconvulsive therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials